Skip to main content
SpringerLink
Log in

Dual effect of docosahexaenoic acid (attenuation or amplification) on C22:0-, C24:0-, and C26:0-Induced mitochondrial dysfunctions and oxidative stress on human neuronal SK-N-BE cells

  • Published:
The journal of nutrition, health & aging

Abstract

Increased levels of C22:0, C24:0 and C26:0 were found in cortical lesions of patients with Alzheimer’s disease (AD). So, it was of interest to precise the cytotoxic effects of these fatty acids, and to determine whether docosahexaenoic acid (DHA), described to prevent AD, can attenuate their eventual side effects. Human neuronal SK-N-BE cells were cultured in the absence or presence of C22:0, C24:0 or C26:0 (0.1–20 μM) without or with DHA (50–150 μM). C22:0, C24:0 and C26:0 induce an inhibition of cell growth, a loss of Δψm, an overproduction of reactive oxygen species (ROS), a decrease of reduced glutathione, and a lipid peroxidation. DHA attenuates C22:0, C24:0 and C26:0 induced-mitochondrial dysfunctions and/or cell growth inhibition measured with MTT whatever the concentrations considered, whereas it can either decrease or amplify (especially at 150 μM) ROS overproduction. C22:0, C24:0 and C26:0 have neurotoxic activities, and depending on its concentration, DHA attenuates or not fatty acid-induced side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9, 119–128.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Zhou ZD, Chan CH, Ma QH, Xu XH, Xiao ZC, Tan EK. The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease. Cell Adh Migr. 2011;5, 280–292.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Kurz A, Perneczky R. Amyloid clearance as a treatment target against Alzheimer’s disease. J Alzheimers Dis. 2011;24 Suppl 2, 61–73.

    CAS  PubMed  Google Scholar 

  4. Cavallucci V, D’Amelio M, Cecconi F. Aβ toxicity in Alzheimer’s disease. Mol Neurobiol. 2012;45, 366–378.

    Article  CAS  PubMed  Google Scholar 

  5. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res. 2010;7, 656–664.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Grimm MO, Rothhaar TL, Hartmann T. The role of APP proteolytic processing in lipid metabolism. Exp Brain Res. 2012;217, 365–375.

    Article  CAS  PubMed  Google Scholar 

  7. Björkhem I, Cedazo-Minguez A, Leoni V, Meaney S. Oxysterols and neurodegenerative diseases. Mol. Aspects Med. 2009;30, 171–179.

    Article  PubMed  Google Scholar 

  8. Iuliano L. Pathways of cholesterol oxidation via non-enzymatic mechanisms. Chem Phys Lipids. 2011;164, 457–468.

    Article  CAS  PubMed  Google Scholar 

  9. Vaya J, Schipper HM. Oxysterols, cholesterol homeostasis, and Alzheimer disease. J Neurochem. 2007;102, 1727–1237.

    Article  CAS  PubMed  Google Scholar 

  10. Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9, 106–118.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Titorenko VI, Terlecky SR. Peroxisome metabolism and cellular aging. Traffic. 2011;12, 252–259.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Schrader M, Fahimi HD. The peroxisome: still a mysterious organelle. Histochem Cell Biol. 2008;129, 421–440.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Lizard G, Rouaud O, Demarquoy J, Cherkaoui-Malki M, Iuliano L. Potential roles of peroxisomes in Alzheimer’s disease and in dementia of the Alzheimer’s type. J Alzheimers Dis. 2012;29, 241–254.

    CAS  PubMed  Google Scholar 

  14. Santos MJ, Quintanilla RA, Toro A, Grandy R, Dinamarca MC, Godoy JA, Inestrosa NC. Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J Biol Chem. 2005;280, 41057–41068.

    Article  CAS  PubMed  Google Scholar 

  15. Shi R, Zhang Y, Shi Y, Shi S, Jiang L. Inhibition of peroxisomal β-oxidation by thioridazine increases the amount of VLCFAs and Aβ generation in the rat brain. Neurosci Lett. 2012;528, 6–10.

    Article  CAS  PubMed  Google Scholar 

  16. Cimini A, Moreno S, D’Amelio M, Cristiano L, D’Angelo B, Falone S, Benedetti E, Carrara P, Fanelli F, Cecconi F, Amicarelli F, Cerù MP. Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer’s disease: a role for peroxisomes. J Alzheimers Dis. 2009;18, 935–952.

    CAS  PubMed  Google Scholar 

  17. Fanelli F, Sepe S, D’Amelio M, Bernardi C, Cristiano L, Cimini A, Cecconi F, Ceru MP, Moreno S. Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer’s disease. Mol Neurodegener. 2013;8: 8. doi: 10.1186/1750-1326-8-8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Kou J, Kovacs GG, Höftberger R, Kulik W, Brodde A, Forss-Petter S, Hönigschnabl S, Gleiss A, Brügger B, Wanders R, Just W, Budka H, Jungwirth S, Fischer P, Berger J. Peroxisomal alterations in Alzheimer’s disease. Acta Neuropathol. 2011;122, 271–283.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Cai Z, Zhao B, Ratka A. Oxidative stress and β-amyloid protein in Alzheimer’s disease. Neuromolecular Med. 2011;13, 223–250.

    Article  CAS  PubMed  Google Scholar 

  20. Maruszak A, Zekanowski C. Mitochondrial dysfunction and Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35, 320–330.

    Article  CAS  PubMed  Google Scholar 

  21. Baarine M, Ragot K, Athias A, Nury T, Kattan Z, Genin EC, Andreoletti P, Ménétrier F, Riedinger JM, Bardou M, Lizard G. Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-a on oligodendrocytes and astrocytes. Neurotoxicology 2012;33, 212- 218.

    Article  CAS  PubMed  Google Scholar 

  22. Baarine M, Andréoletti P, Athias A, Nury T, Zarrouk A, Ragot K, Vejux A, Riedinger JM, Kattan Z, Bessede G, Trompier D, Savary S, Cherkaoui-Malki M, Lizard G. Evidence of oxidative stress in very long chain fatty acid-treated oligodendrocytes and potentialization of ROS production using RNA interferencedirected knockdown of ABCD1 and ACOX1 peroxisomal proteins. Neuroscience 2012;213, 1–18.

    Article  CAS  PubMed  Google Scholar 

  23. Zarrouk A, Vejux A, Nury T, El Hajj HI, Haddad M, Cherkaoui-Malki M, Riedinger JM, Hammami M, Lizard G. Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-N-BE). Oxid Med Cell Longev. 2012;2012:623257. doi: 10.1155/2012/623257.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005;115, 2774–2783.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Stark DT, Bazan NG. Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer’s disease cellular models. Mol Neurobiol. 2011;43, 131–138.

    Article  CAS  PubMed  Google Scholar 

  26. Tanito M, Brush RS, Elliott MH, Wicker LD, Henry KR, Anderson RE. High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration. J Lipid Res. 2009;50, 807–819.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Muntané G, Janué A, Fernandez N, Odena MA, Oliveira E, Boluda S, Portero-Otin M, Naudí A, Boada J, Pamplona R, Ferrer I. Modification of brain lipids but not phenotype in alpha-synucleinopathy transgenic mice by long-term dietary n-3 fatty acids. Neurochem Int. 2010;56, 318–328.

    Article  PubMed  Google Scholar 

  28. Takemoto Y, Suzuki Y, Horibe R, Shimozawa N, Wanders RJ, Kondo N. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain Dev. 2003;25, 481–487.

    Article  PubMed  Google Scholar 

  29. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 1983;130, 1910–1917.

    CAS  PubMed  Google Scholar 

  30. Rothe G, Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2’,7’-dichlorofluorescin. J Leukoc Biol. 1990;47, 440–448.

    CAS  PubMed  Google Scholar 

  31. Hedley DW, Chow S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 1994;15, 349–358.

    Article  CAS  PubMed  Google Scholar 

  32. Khatoon F, Moinuddin, Alam K, Ali A. Physicochemical and immunological studies on 4-hydroxynonenal modified HSA: implications of protein damage by lipid peroxidation products in the etiopathogenesis of SLE. Hum. Immunol. 2012;73, 1132–1139.

    Article  CAS  PubMed  Google Scholar 

  33. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem. 2008;283, 21837- 21841.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Pikuleva IA. Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos. 2006;34, 513–520.

    Article  CAS  PubMed  Google Scholar 

  35. Singh S, Kushwah AS, Singh R, Farswan M, Kaur R. Current therapeutic strategy in Alzheimer’s disease. Eur Rev Med Pharmacol Sci. 2012;16, 1651–1664.

    CAS  PubMed  Google Scholar 

  36. Vejux A, Lizard G. Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med. 2009;30, 153–170.

    Article  CAS  PubMed  Google Scholar 

  37. Dacks PA, Shineman DW, Fillit HM. Current evidence for the clinical use of longchain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer’s disease. J Nutr Health Aging. 2013;17, 240–251.

    Article  CAS  PubMed  Google Scholar 

  38. Ouellet M, Emond V, Chen CT, Julien C, Bourasset F, Oddo S, LaFerla F, Bazinet RP, Calon F. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. Neurochem Int. 2009;55, 476–482.

    Article  CAS  PubMed  Google Scholar 

  39. Eckert GP, Lipka U, Muller WE. Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria. Prostaglandins Leukot Essent Fatty Acids. 2013;88, 105–114.

    Article  CAS  PubMed  Google Scholar 

  40. Vandal M, Alata W, Tremblay C, Rioux-Perreault C, Salem Jr N, Calon F, Plourde M. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2. J Neurochem. 2014;129:516–526.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Equipe ‘Biochimie du Peroxysome, Inflammation et Métabolisme Lipidique’ EA 7270 / Université de Bourgogne, INSERM, Dijon, France

    A. Zarrouk, T. Nury & Gérard Lizard

  2. Faculté de Médecine, LR12ES05, Lab-NAFS ‘Nutrition - Functional Food & Vascular Health’, Université de Monastir, Monastir, Tunisia

    A. Zarrouk & M. Hammami

  3. Centre de Lutte Contre le Cancer GF Leclerc, Biologie Médicale, Dijon, France

    J. M. Riedinger

  4. Service de Neurologie, CHU de Dijon, Dijon, France

    O. Rouaud

  5. Laboratoire BIO-peroxIL - EA 7270/INSERM, Faculté des Sciences Gabriel, 6 Bd Gabriel, 21000, Dijon, France

    Gérard Lizard

Authors
  1. A. Zarrouk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Nury
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. M. Riedinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Rouaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Hammami
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gérard Lizard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gérard Lizard.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zarrouk, A., Nury, T., Riedinger, J.M. et al. Dual effect of docosahexaenoic acid (attenuation or amplification) on C22:0-, C24:0-, and C26:0-Induced mitochondrial dysfunctions and oxidative stress on human neuronal SK-N-BE cells. J Nutr Health Aging 19, 198–205 (2015). https://doi.org/10.1007/s12603-014-0518-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-014-0518-0

Keywords

Search

Navigation